• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® BILIARY CONTROLLED-RELEASE STENT - UNCOVERED; FGE CATHETER, BILIARY, DIAGNOSTIC - BILIARY STENT - METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® BILIARY CONTROLLED-RELEASE STENT - UNCOVERED; FGE CATHETER, BILIARY, DIAGNOSTIC - BILIARY STENT - METAL Back to Search Results
Catalog Number EVO-10-11-8-B
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Date of Event 04/15/2016
Type of Reportable Event Serious Injury
Event or Problem Description
(b)(6) 2015 date of first implant procedure in common bile duct due to cholangiocarcinoma (bile duct cancer).No adverse events related to the procedure.Patient received chemotherapy from (b)(6) 2016.Re-current biliary obstructions (b)(6) 2016.Occlusion within stent due to outgrowth of tumoral tissue in the duodenal papilla.134 days post procedure.Due to tissue or tumor overgrowth.Treatment endoscopic intervention placement of another stent.The site determined the event to not be related to the study device or procedure, related to progression of cancer.Patient death (b)(6) 2016.Due to primary disease progression.The reintervention for recurrent biliary obstruction was noted to be successful.On (b)(6) 2016, the patient died of primary disease progression.
 
Additional Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Additional Manufacturer Narrative
Device evaluation the evo-10-11-8-b device of lot number c1164028 involved in this complaint was not returned for evaluation.With the information provided, a document-based investigation was conducted.This file was created in response to the attached pmcf study.Manufacturing records review: prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.A review of the manufacturing records did not reveal any discrepancies that could have contributed to this complaint issue.Instructions for use and/label review: it should be noted that the instructions for use (ifu0056) lists ¿stent occlusion¿ as a potential adverse event.There is no evidence to suggest that the customer did not follow the instructions for use.Image review an image was not returned for evaluation.Root cause analysis a definitive root cause could not be determined.A possible root cause can be attributed to patient pre-existing conditions and/or a known potential adverse event.From the study it is known that the patient had bile duct cancer.The cause of the stent obstruction was reported to be due to tissue or tumour overgrowth.Also, as previously noted, ¿stent occlusion¿ is listed as a potential adverse event in the ifu.As per medical advisor input the device did not cause or contribute to the biliary obstruction, however this file was conservatively opened from a regulatory perspective.Confirmation of complaint: the complaint is confirmed based on customer and/or rep testimony.Confirmed quantity of (b)(4) used device.Corrective action/correction complaints of this nature will continue to be monitored for similar events.Summary of investigation according to the initial reporter, the stent was implanted on the (b)(6) 2015.The patient experienced recurrent biliary obstruction 134 days post procedure, the patient required the placement of another stent as a result of this occurrence, and it was reported that the patient recovered/stabilised following this.A possible root cause can be attributed to patient pre-existing conditions and/or a known potential adverse event.Complaints of this nature will continue to be monitored for similar events.Confirmed quantity of (b)(4) used device.Patient death was reported on the (b)(6) 2016, the cause of death was due to primary disease progression.
 
Event or Problem Description
A supplemental report is being submitted due to completion of the investigation on (b)(6)2025.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® BILIARY CONTROLLED-RELEASE STENT - UNCOVERED
Common Device Name
FGE CATHETER, BILIARY, DIAGNOSTIC - BILIARY STENT - METAL
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key20817421
Report Number3001845648-2024-00713
Device Sequence Number7804460
Product Code FGE
UDI-Device Identifier10827002231297
UDI-Public(01)10827002231297(17)171021(10)C1164028
Combination Product (Y/N)N
PMA/510(K) Number
K121430
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Expiration Date10/21/2017
Device Catalogue NumberEVO-10-11-8-B
Device Lot NumberC1164028
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date04/15/2016
Event Location Hospital
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/05/2024
Supplement Date Received by Manufacturer11/05/2024
Initial Report FDA Received Date12/02/2024
Supplement Report FDA Received Date01/23/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/21/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age62 YR
Patient SexMale
Patient Weight78 KG
-
-